Quantitative Evaluation of c-met Expression in PBMNCs by Combined In Situ Hybridization and Immunocytology
Cell Fractions* . | PHA . | PHA/LPS . | PHA/LPS . | Control . |
---|---|---|---|---|
. | 17 h . | 17 h . | 7 d . | 7 d . |
c-met+ (%) | 1.5 | 2 | 1 | 0 |
c-met+/CD 68+ (%) | 18 | 27 | 25 | 0 |
c-met+/CD 3+ (%) | 0 | 0 | 0 | ND |
CD 68+/c-met+ (%)† | 98 | 98 | 100 | No c-met signal |
CD 3+/c-met+ (%)† | 3 | 2 | NE | ND |
Cell Fractions* . | PHA . | PHA/LPS . | PHA/LPS . | Control . |
---|---|---|---|---|
. | 17 h . | 17 h . | 7 d . | 7 d . |
c-met+ (%) | 1.5 | 2 | 1 | 0 |
c-met+/CD 68+ (%) | 18 | 27 | 25 | 0 |
c-met+/CD 3+ (%) | 0 | 0 | 0 | ND |
CD 68+/c-met+ (%)† | 98 | 98 | 100 | No c-met signal |
CD 3+/c-met+ (%)† | 3 | 2 | NE | ND |